The IDO Battle Gets Ugly Post author:Sam Post published:October 24, 2017 Post category:BioPharma Incyte has been at the forefront of the IDO race with its candidate epacadostat. Source: BioSpace You Might Also Like TCR2 Therapeutics Snags $125 Million To Expand T-Cell Program March 20, 2018 Vivasure Medical Enrolls First Patient In Frontier IV Clinical Trial October 12, 2017 FDA Approves 23andMe’s Direct-to-Consumer Genetic Test for Cancer March 6, 2018
